SKI Market

Indian Indices

Nifty

25,181.80 135.65
(0.54%)

Sensex

82,541.96 369.86
( 0.45%)

Bank Nifty

56,192.05 173.80
( 0.31%)

Nifty IT

35,628.50 396.30
( 1.12%)

Global Indices

Nasdaq

46,372.36 -250.43
(-0.54%)

Dow Jones

6,754.41 -20.31
(-0.30%)

Hang Seng

48,554.08 819.09
(1.72%)

Nikkei 225

9,509.40 -39.47
(-0.41%)

Forex

USD-INR

88.77 0.03
(0.03%)

EUR-INR

103.17 -0.42
(-0.41%)

GBP-INR

118.97 -0.30
(-0.26%)

JPY-INR

0.58 -0.01
(-0.99%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Accent Microcell Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

92465

INE0Q5D01013

97.7797217

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ACCENTMIC

18.61

615.32

EPS(TTM)

Face Value()

Div & Yield %

13.78

0.39

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	264.58	245.50	197.27	165.71	132.57	131.38
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	264.58	245.50	197.27	165.71	132.57	131.38
Other Income	6.41	3.63	2.49	1.83	2.25	3.99
Stock Adjustments	3.85	-14.62	9.71	6.94	8.94	3.61
Total Income	274.84	234.51	209.47	174.48	143.76	138.98
EXPENDITURE :
Raw Materials	165.35	131.11	129.19	120.28	99.05	88.69
Power & Fuel Cost	20.14	22.91	23.26	3.34	3.16	4.87
Employee Cost	15.49	13.30	8.97	7.62	6.93	9.42
Other Manufacturing Expenses	9.52	8.99	9.63	9.94	9.85	10.49
Selling & Administrative Expenses	14.38	12.83	16.54	17.51	10.65	12.53
Miscellaneous Expenses	1.63	3.27	0.45	0.98	1.18	0.20
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	226.51	192.40	188.03	159.67	130.82	126.21
Operating Profit	48.32	42.11	21.44	14.81	12.94	12.77
Interest	0.35	1.15	2.53	3.07	3.38	3.41
Gross Profit	47.97	40.96	18.91	11.74	9.56	9.36
Depreciation	4.21	4.43	4.11	4.15	3.55	3.30
Profit Before Tax	43.76	36.53	14.80	7.59	6.01	6.06
Tax	10.67	6.39	2.59	1.66	1.19	1.01
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.03	-0.03	-0.02	0.04	0.01	0.87
Reported Net Profit	33.06	30.17	12.23	5.89	4.80	4.18
Extraordinary Items	0.00	-0.83	0.00	0.00	-0.22	0.00
Adjusted Net Profit	33.06	31.00	12.23	5.89	5.02	4.18
Adjustment below Net Profit	0.00	0.00	0.00	0.00	-3.27	0.00
P & L Balance brought forward	65.75	36.62	24.38	12.95	11.42	7.24
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	2.10	1.04	0.00	0.43	0.00	0.00
P & L Balance carried down	96.71	65.75	36.62	18.41	12.95	11.42
Dividend	2.10	1.04	0.00	0.43	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	10.00	10.00	8.00	8.00	10.00	0.00
Dividend Per Share(Rs)	1.00	1.00	0.80	0.80	1.00	0.00
Earnings Per Share-Unit Curr	15.71	14.34	9.45	4.57	11.17	9.71
Earnings Per Share(Adj)-Unit Curr	14.86	13.56	9.45	4.57	11.17	9.71
Book Value-Unit Curr	92.57	77.86	38.96	24.87	61.92	58.36
Book Value(Adj)-Unit Curr	87.56	73.65	38.96	24.87	61.92	58.36

25,181.80 135.65 (0.54%)

82,541.96 369.86 ( 0.45%)

56,192.05 173.80 ( 0.31%)

35,628.50 396.30 ( 1.12%)

46,372.36 -250.43 (-0.54%)

6,754.41 -20.31 (-0.30%)

48,554.08 819.09 (1.72%)

9,509.40 -39.47 (-0.41%)

88.77 0.03 (0.03%)

103.17 -0.42 (-0.41%)

118.97 -0.30 (-0.26%)

0.58 -0.01 (-0.99%)